Pubmed: Chimeric antigen T cells

Pubmed: Bispecific antibodies & BiTE

GEN Highlights

• An error occurred while fetching this feed: https://www.genengnews.com/gen.rss

Fiercebiotech News

• Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring (2026/08/05 18:13)

  Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”
• Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’ (2026/08/05 14:08)

  Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce has learned.
• Fecal transplant increases tolerance to peanuts sixfold in small food allergy trial (2026/08/05 10:35)

  Fecal transplants can increase tolerance to peanuts sixfold in people with food allergies, new research out of Boston Children’s Hospital has suggested.
• Lilly drops another gene therapy trial from $1B Prevail buyout (2026/08/05 08:37)

  Eli Lilly has axed another trial of a gene therapy acquired in its $1 billion Prevail Therapeutics buyout, further denting the drugmaker’s chances of delivering a return on its investment.
• Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data (2026/08/05 03:40)

  Novo Nordisk’s CEO admitted the Danish pharma has had “a couple of setbacks” in the wake of mixed data for CagriSema and its cardiovascular hopeful ziltivekimab, while stressing that the company is already on the hunt for bolt-on deals.
• Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO (2026/08/05 00:10)

  Attovia Therapeutics has accreted a hefty $289 million from its IPO to power its anti-itch drugs through clinical development, marking another upsized listing in what has become a banner year for biotech Nasdaq debuts.
• Icon inks Anthropic partnership to deploy Claude into clinical trials (2026/08/04 13:30)

  Contract research organization Icon announced a multi-year collaboration with Anthropic this week to bring Claude’s AI capabilities to clinical trials.
• Amgen drops early-stage obesity drug, upping pressure on MariTide (2026/08/04 13:13)

  Amgen has ended development of its early-stage obesity drug AMG 513, foisting its hopes for a slice of the massive weight loss market onto the shoulders of phase 3 candidate MariTide.
• Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey (2026/08/04 12:52)

  Expedition Therapeutics has secured an oversubscribed $115 million series B financing from a line-up of big-name investors to propel its lead DPP1 inhibitor through phase 2.
• Smith & Nephew cuts 2026 outlook as US knee implant sales slide (2026/08/04 11:23)

  Smith & Nephew has lowered its 2026 sales outlook after weakness in U.S. orthopedics and wound care outweighed stronger growth in sports medicine.

Google News:Health

• The one thing Ozempic still can’t fix - vox.com

  The one thing Ozempic still can’t fix  vox.comOzempic is changing workplace etiquette — and making everyone uncomfortable  businessinsider.comExperts Say GLP-1 Usage May Affect Your Mental Health—Even if You’re Not on One  womenshealthmag.com'My body is your worst nightmare': Loving your body in the GLP-1 era  abc.net.auWeight Loss Medication Marketing and First Nations People: Disease Awareness or Corporate Profit?  Medical Journal of Australia (MJA)
• Here’s what happens to your brain when you stop drinking alcohol - Yahoo

  Here’s what happens to your brain when you stop drinking alcohol  YahooColumn | Here’s what happens to your brain when you stop drinking alcohol  The Washington PostNeurologists Warn This Habit Is Aging Your Brain Faster Than You Think  EatingWellDrinking: Damned If You Do, Damned If You Don’t.  Outside the Beltway
• What we’ve learned about Covid-19 since the pandemic - CNN

  What we’ve learned about Covid-19 since the pandemic  CNN
• GPs’ breast cancer guidelines ‘miss’ 95% of young women who will develop disease - theguardian.com

  GPs’ breast cancer guidelines ‘miss’ 95% of young women who will develop disease  theguardian.comBreast cancer checks missing most women under 50 who are at risk, says study  BBCComparison of NICE criteria with the BOADICEA multifactorial risk model to guide breast cancer risk assessment and referral amongst women under age 50 within primary care | British Journal of Cancer  nature.comBreast Cancer Risk Criteria Miss Nearly All Women Who Later Develop Cancer  Inside Precision MedicineWomen under 50 at risk of breast cancer are not being referred - study  Sky News
• Popular weight-loss drugs may help protect against a deadly disease, doctor says - Fox News

  Popular weight-loss drugs may help protect against a deadly disease, doctor says  Fox NewsCan Ozempic prevent cancer? A doctor explains why the headlines are easy to misread  Japan TodayGlucagon-Like Peptide-1 (GLP-1)-Based Therapies and Hematological Malignancies: A Narrative Review of Current and Emerging Evidence  CureusReal-World Analysis Explores GLP-1 Use and Overall Survival  Targeted OncologyCould Drugs Developed for Diabetes and Obesity Help Slow Cancer Spread? - CancerWorld  Oncodaily
• Coronary Artery Calcium Scoring May Refine Heart Risk Estimate and Statin Decisions - Medscape

  Coronary Artery Calcium Scoring May Refine Heart Risk Estimate and Statin Decisions  MedscapeSimplified Risk Score Predicts Coronary Calcium on CTA  MedscapeIncidental Coronary Calcium on Routine Chest CT May Predict Cardiovascular Risk: Study  Medical Dialogues
• What Is Ozempic Hair'? A Doctor Explains The Alarmingly Common Weight Loss Side Effect - NDTV

  What Is Ozempic Hair'? A Doctor Explains The Alarmingly Common Weight Loss Side Effect  NDTVCan GLP-1 drugs like Ozempic increase hair loss risk?  Medical News TodayOzempic is giving people 'temporal hollowing.' Doctors are sounding an alarm.  USA TodayThe Risk of Hair Loss May Be "Significantly Greater" With This GLP-1 Drug Than With Others  AllureCollagen and hair loss products surge as weight loss drug use grows  TheIndustry.beauty
• New HEALTH Survey Finds Americans Don’t Just Want to Live Longer—They Want to Age Well - Health: Trusted and Empathetic Health and Wellness Information

  New HEALTH Survey Finds Americans Don’t Just Want to Live Longer—They Want to Age Well  Health: Trusted and Empathetic Health and Wellness InformationAmericans Prioritize ‘Aging Well’ Over Living Longer: Survey  People.comWhy ‘ageing well’ is replacing the anti-ageing obsession  Free Malaysia TodayWhy More Adults Are Focusing on Healthy Aging Instead of Anti-Aging  Charleston Gazette-MailThe Healthy Aging Conversation Often Leaves Out People With Chronic Conditions  AOL.com
• Scientists Propose New Strategy in Fight against High Blood Pressure - Sci.News

  Scientists Propose New Strategy in Fight against High Blood Pressure  Sci.NewsExperts say blood pressure guidelines are missing half the equation  ScienceDailyHave High Blood Pressure? Scientists Just Discovered Cutting Out Salt Is Only Half the Dietary Equation  inc.comReport Argues Raising Potassium Belongs Alongside Cutting Sodium in Blood Pressure Advice  medicaldaily.comMedical Xpress Highlights Fukagawa Research on New Strategy for Controlling Hypertension  University of Vermont
• Sarah Urbut: Predicting Your Health Arc - Ground Truths | Eric Topol

  Sarah Urbut: Predicting Your Health Arc  Ground Truths | Eric Topol
• Researchers discover immune 'off switch' used by cancer cells - Medical Xpress

  Researchers discover immune 'off switch' used by cancer cells  Medical XpressOxford‑led study uncovers mechanism of immune cell decision‑making  Новости GxPResearchers identify immune “off switch” exploited by cancer cells  Bioengineer.orgScientists decipher how T cells sense enemies—such as cancer—at point of contact  Medical Xpress
• Pancreatic cancer drug now available in Cleveland offers new hope - WKYC

  Pancreatic cancer drug now available in Cleveland offers new hope  WKYCDaraxonrasib: A Breakthrough in Pancreatic Ductal Adenocarcinoma  CureusRecent advances in pancreatic cancer treatment  South Carolina Public RadioRASolute-302 Data Signal a New Era for Pancreatic Cancer Drug Development  CancerNetworkA New Hope for Pancreatic Cancer  Yale Medicine
• Autism Spectrum May Be Too Broad - Neuroscience News

  Autism Spectrum May Be Too Broad  Neuroscience NewsAutism spectrum disorder: has it lost its meaning and is it leading to misdiagnosis? | Psychological Medicine  Cambridge University Press & AssessmentHas the definition of autism become too broad to be useful?  Medical XpressWhy autism may not be on a ‘spectrum’ after all  The IndependentLeading expert says ‘anyone can have autism now’ as she claims spectrum is too broad  The Independent
• Longevity and protein: Restricting 3 amino acids may help extend life - Medical News Today

  Longevity and protein: Restricting 3 amino acids may help extend life  Medical News TodayCould Eating Less Protein Help You Age Better and Live Longer?  Time MagazineStudy suggests eating less protein could be key to healthy aging for most adults  ABC News - Breaking News, Latest News and VideosEating less protein may ‘slow’ ageing. But here’s why the evidence isn’t clear-cut  theconversation.comThe protein craze may not be for everyone  Science News
• Going vegan for just a month slowed signs of aging in the body, study finds - The Independent

  Going vegan for just a month slowed signs of aging in the body, study finds  The IndependentOne Month on a Vegan Diet Shifts Epigenetic Patterns Associated with Aging and Inflammation  UC San Diego TodayVegan diet can change inflammation, improve how body ages, study finds  KPBSGoing vegan may keep you feeling younger. Study reveals how  ThePrintGoing vegan for just four weeks may help slow biological ageing, study suggests  Vegan Food & Living
• As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill - Fierce Pharma

  As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill  Fierce PharmaHow Lipfendra, Inclisiran, and New Guidelines Are Changing Cholesterol Management  HealthlineLipfendra vs statins: How these cholesterol-lowering drugs compare  Medical News TodayCardiologists Weigh Where the First Oral PCSK9 Pill Fits Now That the FDA Has Approved It  medicaldaily.comNew medication could lower cholesterol by 60%, experts say  FOX Carolina News
• One Supplement Ingredient May Help Immune System Fight Cancer, Study Finds - Newsweek

  One Supplement Ingredient May Help Immune System Fight Cancer, Study Finds  NewsweekThis amino acid may help the body fight tumors and viral infections  Medical XpressA simple supplement could help the immune system fight cancer and viruses  ScienceDailyHow one amino acid might help fight colon cancer and infections  Science NewsArginine Availability May Shape How Well T Cells See Tumors and Viruses  Inside Precision Medicine
• Metro Atlanta mother of two misdiagnosed with cancer, given full hysterectomy after alleged lab mix-up - 11Alive.com

  Metro Atlanta mother of two misdiagnosed with cancer, given full hysterectomy after alleged lab mix-up  11Alive.comFulton County woman sues Kaiser over cancer surgery mix-up  FOX 5 AtlantaWoman says she had surgery for cancer, but it was a misdiagnosis  WSB-TVAtlanta mom Cassandra Barksdale misdiagnosed with aggressive cancer, underwent full hysterectomy after lab mix-up: lawsuit  New York PostGeorgia woman had unnecessary hysterectomy after lab mix-up and cancer misdiagnosis, lawsuit says  NBC News
• Painesville mom says bat infestation at condominium complex has gone unresolved for weeks, raising health concerns - FOX 8 News

  Painesville mom says bat infestation at condominium complex has gone unresolved for weeks, raising health concerns  FOX 8 News
• Eugene Floyd Briggs - Post Bulletin

  Eugene Floyd Briggs  Post Bulletin